Serial #86023517
DEAD

Serial Number

86023517

Owner

TELERx Marketing, Inc.

Attorney

HOPE V. SHOVEIN

First Use Date

May 21, 2014

Filing Date

Jul 30, 2013

Add to watchlist:

No watchlists yet
View on USPTO

Serial #86023517 Trademark

Serial Number: 86023517 • Registration: 4739769

Serial #86023517 is a trademark filed by TELERx Marketing, Inc. on July 30, 2013. The trademark is classified under Class 36 (Insurance & Financial), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

TELERx Marketing, Inc. (38 trademarks)

Springhouse, PA 19477

Entity Type: 03

Trademark Details

Filing Date

July 30, 2013

Registration Date

May 19, 2015

First Use Anywhere

May 21, 2014

First Use in Commerce

May 21, 2014

Published for Opposition

July 15, 2014

Cancellation Date

November 26, 2021

Goods & Services

Telecommunications services provided via an interactive voice response system, namely, call routing, call forwarding, call screening, call recording, telephone voice messaging, electronic messaging services to deliver information to customers of others

Business process outsourcing services for others in the fields of pharmacy and healthcare, namely, pharmaceutical benefit management services, including verification of benefit eligibility and patient enrollment

Customer service management and customer relationship management services for others in the fields of pharmacy and healthcare, healthcare and pharmacy access and reimbursement programs, and healthcare and consumer packaged goods; business process outsourcing services for others in the fields of pharmacy and healthcare, healthcare and pharmacy access and reimbursement (A and R) programs, and healthcare and consumer packaged goods (CPG), namely, providing consumers with information about products and services of others in response to consumer interactions such as inquiries and complaints, and using such inquiries to: increase product/service sales via inbound up-selling and cross-selling of products and services, increase repeat purchases and lifetime value, and improve and increase brand loyalty; order fulfillment services; administration of patient reimbursement programs with regard to medication and treatment; marketing analysis services to provide trends and to gain insight into consumer behavior; business and marketing services for others provided via an interactive voice response system, namely, processing telephone inquiries regarding products and services of others, responding to customer inquiries regarding products and services of others, and telephone order-taking services; administration of patient support and adherence programs featuring appointment scheduling services, physician referrals, and customer follow-ups for customer service and business purposes; marketing analysis and marketing services, namely, monitoring and administration of branded social media advertising for others

Business process outsourcing services for others in the fields of pharmacy and healthcare, namely, providing information, advice, and consulting in the field of drug safety and pharmacovigilance as it relates to drug safety; providing drug safety services and pharmacovigilance services related to drug safety, namely, collecting, analyzing, and processing data related to adverse events and product quality complaints, aggregate reporting of adverse events and product quality complaints, and product life cycle case handling related to adverse events and product quality complaints

Business process outsourcing services for others in the fields of pharmacy and healthcare, namely, providing and administering disease management programs including remote assistance, advice, and support; patient support and adherence services, namely, providing doctor's appointment and prescription refill reminder services and following up with patients to determine whether they are adhering to medical advice and taking prescribed medications

Technical support services, namely, troubleshooting of computer software problems; pharmacovigilance services for others, namely, scientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical products, assessment of risks presented by certain pharmaceutical products or combinations thereof, and product safety testing and consultation related thereto in the field of pharmaceuticals

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 26, 2021 C8..
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 5, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 5, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 5, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 5, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 5, 2020 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 19, 2020 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 28, 2016 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 28, 2016 COAR
REGISTERED-PRINCIPAL REGISTER
May 19, 2015 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 17, 2015 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 16, 2015 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 11, 2015 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Apr 10, 2015 SUPC
SOU EXTENSION 1 GRANTED
Apr 10, 2015 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 9, 2015 AITU
USE AMENDMENT FILED
Mar 4, 2015 IUAF
SOU EXTENSION 1 FILED
Mar 4, 2015 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 4, 2015 EEXT
TEAS STATEMENT OF USE RECEIVED
Mar 4, 2015 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 9, 2014 NOAM
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 5, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 5, 2014 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 15, 2014 NPUB
PUBLISHED FOR OPPOSITION
Jul 15, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 25, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 10, 2014 PREV
ASSIGNED TO LIE
Jun 9, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 27, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
May 27, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 27, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
May 27, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 27, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 5, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 20, 2013 GNRN
NON-FINAL ACTION E-MAILED
Nov 20, 2013 GNRT
NON-FINAL ACTION WRITTEN
Nov 20, 2013 CNRT
ASSIGNED TO EXAMINER
Nov 13, 2013 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 7, 2013 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 6, 2013 NWOS
NEW APPLICATION ENTERED
Aug 2, 2013 NWAP